Xinhuanet reports that a Chinese vaccine against the Hepatitis E Virus (HEV) has entered clinical trial in the United States after two U.S. volunteers were vaccinated on May 1, 2019, according to Xiamen University. In a three-phase process, the Xiamen University will...
Sponsored by the National Institutes of Health (NIH), a Chinese vaccine against the Hepatitis E virus (HEV) has been approved by the U.S. Food and Drug Administration (FDA). Clinical trials will commence in April of 2019. Sold under the trade name Hecolin, it was...
Pin It on Pinterest
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site you consent to our use of cookies.Ok
